Fate of the antibiotic sulfamethoxazole and its two major human metabolites in a water sediment test

Environmental Science and Technology

Volumn 43, Issue 9, 2009, Pages 3135-3141

  Radke, Michael ^a   Lauwigi, Christoph ^a   Heinkele, Georg ^b,c   Múrdter, Thomas E ^b,c   Letzel, Marion ^d  

^a UNIVERSITY OF BAYREUTH   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Bavarian Environmental Agency   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SULFAMETHOXAZOLE; AQUEOUS PHASE; BIODEGRADATION POTENTIALS; ENVIRONMENTAL CONDITIONS; ENVIRONMENTAL FATE; GLUCURONIDE; HALF LIVES; HUMAN METABOLITES; PARENT COMPOUNDS; PH CONDITION; RIVER SEDIMENTS; SULFAMETHOXAZOLE; TEST SYSTEMS; WASTEWATER TREATMENT PLANTS; WATER SEDIMENTS;

ANTIBIOTICS; BIOCHEMISTRY; BIODEGRADATION; BIOLOGICAL WATER TREATMENT; BIOMOLECULES; DEGRADATION; METABOLISM; METABOLITES; MICROBIOLOGY; RIVERS; SORPTION; SULFUR COMPOUNDS; TESTING; VETERINARY MEDICINE; WASTEWATER; WASTEWATER RECLAMATION; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

SEDIMENTOLOGY;

N4 ACETYL SULFAMETHOXAZOLE; SULFAMETHOXAZOLE; SULFAMETHOXAZOLE N1 GLUCURONIDE; UNCLASSIFIED DRUG;

ANTIBIOTICS; ENVIRONMENTAL CONDITIONS; FLUVIAL DEPOSIT; METABOLITE; POLLUTANT REMOVAL; SORPTION; SULFUR COMPOUND; WASTE FACILITY; WASTEWATER; WATER TREATMENT;

AQUEOUS SOLUTION; ARTICLE; BIOREMEDIATION; METABOLITE; PH; RIVER; SEDIMENT; WATER ABSORPTION; WATER ANALYSIS; WATER SAMPLING; WATER SUPPLY;

ANTI-BACTERIAL AGENTS; ENVIRONMENTAL REMEDIATION; GEOLOGIC SEDIMENTS; HUMANS; KINETICS; RIVERS; SULFAMETHOXAZOLE; TIME FACTORS; WATER; WATER POLLUTANTS, CHEMICAL;

EID: 66449097096     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es900300u     Document Type: Article

References (38)

1. Ternes, T. A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32 (11), 3245-3260.
2. Boxall, A. B. A.; Fogg, L. A.; Blackwell, P. A.; Kay, P.; Pemberton, E. J.; Croxford, A. Veterinary medicines in the environment. In Reviews of Environmental Contamination and Toxicology; Springer-Verlag: New York, 2004; Vol. 180, pp 1-91.
3. Bund/Länder-Ausschuss Chemikaliensicherheit Report Arznei-mittel in der Umwelt - Auswertung der Untersuchungsergebnisse (in German); Hamburg, 2003; http://blak-uis.server.de/servlet/ is/2146/P-2c.pdf. Accessed Jan. 14, 2009.
4. McEvoy, G. K. AHFS Drug Information; American Society of Health-System Pharmacists: Bethesda, MD, 2004.
5. van der Ven, A. J.; Vree, T. B.; van Ewijk-Benken Kolmer, E. W.; Koopmans, P. P.; van der Meer, J. W. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Br. J. Clin. Pharmacol. 1995, 39, 621-625.
6. van der Ven, A. J.; Mantel, M. A.; Vree, T. B.; Koopmans, P. P.; van der Meer, J. W. Formation and elimination of sulpha-methoxazole hydroxylamine after oral administration of sul-phamethoxazole. Br. J. Clin. Pharmacol. 1994, 38, 147-150.
7. Gill, H. J.; Maggs, J. L.; Madden, S.; Pirmohamed, M.; Park, B. K. The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole. Br. J. Clin. Pharmacol. 1996, 42, 347-353.
8. Ferrari, B.; Mons, R.; Vollat, B.; Fraysse, B.; Paxeus, N.; Lo Giudice, R.; Pollio, A.; Garric, J. Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ. Toxicol. Chem. 2004, 23 (5), 1344-1354.
9. Isidori, M.; Lavorgna, M.; Nardelli, A.; Pascarella, L.; Parrella, A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci. Total Environ. 2005, 346 (1-3), 87-98.
10. Brain, R. A.; Johnson, D. J.; Richards, S. M.; Hanson, M. L.; Sanderson, H.; Lam, M. W.; Young, C.; Mabury, S. A.; Sibley, P. K.; Solomon, K. R. Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. Aquat. Toxicol. 2004, 70 (1), 23-40.
11. Pérez, S.; Eichhorn, P.; Aga, D. Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trime-thoprim at different stages of sewage treatment. Environ. Toxicol. Chem. 2005, 24 (6), 1361-1367.
12. Advanced Chemistry Development (ACD/Labs). Software V8.14 for Solaris; accessed through CAS Scifinder Jan. 14, 2009.
13. Kahle, M.; Stamm, C. Time and pH-dependent sorption of the veterinary antimicrobial sulfathiazole to clay minerals and ferrihydrite. Chemosphere 2007, 68 (7), 1224-1231.
14. Gao, J.; Pedersen, J. A. Adsorption of sulfonamide antimicrobial agents to clay minerals. Environ. Sci. Technol. 2005, 39 (24), 9509-9516.
15. Al-Ahmad, A.; Daschner, F. D.; Kümmerer, K. Biodegradability of cefotiam, ciprofloxacin, Meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria. Arch. Environ. Contam. Toxicol. 1999, 37 (2), 158-163.
16. Lindberg, R. H.; Wennberg, P.; Johansson, M. I.; Tysklind, M.; Andersson, B. A. V. Screening of Human Antibiotic Substances and Determination of Weekly Mass Flows in Five Sewage Treatment Plants in Sweden. Environ. Sci. Technol. 2005, 39 (10), 3421-3429.
17. Göbel, A.; McArdell, C. S.; Joss, A.; Siegrist, H.; Giger, W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372 (2-3), 361-371.
18. Göbel, A.; Thomsen, A.; McArdell, C. S.; Joss, A.; Giger, W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39, 3981-3989.
19. Letzel, M. Verhalten prioritärer organischer Stoffe der Wasser-rahmenrichtlinie in Kläranlagen und beim Eintrag in oberir-dische Gewässer (in German); Report by the Bavarian Environment Agency: Munich, Germany, 2008.
20. Heberer, T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266 (3-4), 175-189.
21. Bergmann, A. LANUV-Report Eintrag von Arzneimitteln und deren Verhalten und Verbleib in der Umwelt (in German); Recklinghausen, 2007; http://www.lanuv.nrw.de/ veroeffentlichungen/fachberichte/fabe2/fabe2.pdf.
22. Ternes, T. A.; Stuber, J.; Herrmann, N.; McDowell, D.; Ried, A.; Kampmann, M.; Teiser, B. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater. Water Res. 2003, 37 (8), 1976-1982.
23. Halling-Sørensen, B.; Nors Nielsen, S.; Lanzky, P. F.; Ingerslev, F.; Holten Lutzhoft, H. C.; Jorgensen, S. E. Occurrence, fate and effects of pharmaceutical substances in the environment- A review. Chemosphere 1998, 36 (2), 357-393.
24. Hirsch, R.; Ternes, T.; Haberer, K.; Kratz, K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225 (1-2), 109-118.
25. Barnes, K. K.; Kolpin, D. W.; Furlong, E. T.; Zaugg, S. D.; Meyer, M. T.; Barber, L. B. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States - I) Groundwater. Sci. Total Environ. 2008, 402 (2-3), 192-200.
26. Heinkele, G.; Mürdter, T. E. Synthesis of [H-2(3)]-labelled sulfamethoxazole and its main urinary metabolites. J. Labelled Compd. Radiopharm. 2007, 50, 1-4.
27. OECD. Test 308: Aerobic and anaerobic transformation in aquatic sediment systems. In OECD Guidelines for the Testing of Chemicals; Organisation for Economic Cooperation and Development: Paris, 2002.
28. Göbel, A.; McArdell, C. S.; Suter, M. J.; Giger, W. Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in waste-water using liquid chromatography coupled to electrospray tandem mass spectrometry. Anal. Chem. 2004, 76 (16), 4756-4764.
29. S imunek, J.; van Genuchten, M. T.; S ejna, M. Development and applications of the HYDRUS and STANMOD software packages, and related codes. Vadose Zone Model. 2008, 7 (2), 587-600; Special Issue.
30. Nakada, N.; Shinohara, H.; Murata, A.; Kiri, K.; Managaki, S.; Sato, N.; Takada, H. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res. 2007, 41 (19), 4373-4382.
31. Drillia, P.; Dokianakis, S. N.; Fountoulakis, M. S.; Kornaros, M.; Stamatelatou, K.; Lyberatos, G. On the occasional biodegradation of pharmaceuticals in the activated sludge process: The example of the antibiotic sulfamethoxazole. J. Hazard. Mater. 2005, 122 (3), 259-265.
32. Johnson, A. C.; Williams, R. J. A Model To Estimate Influent and Effluent Concentrations of Estradiol, Estrone, and Ethinylestra-diol at Sewage Treatment Works. Environ. Sci. Technol. 2004, 38 (13), 3649-3658.
33. Löffler, D.; Römbke, J.; Meller, M.; Ternes, T. A. Environmental fate of pharmaceuticals in water/sediment systems. Environ. Sci. Technol. 2005, 39 (14), 5209-5218.
34. Drillia, P.; Stamatelatou, K.; Lyberatos, G. Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 2005, 60 (8), 1034-1044.
35. Kahle, M.; Stamm, C. Sorption of the veterinary antimicrobial sulfathiazole to organic materials of different origin. Environ. Sci. Technol. 2007, 41 (1), 132-138.
36. Lam, M. W.; Mabury, S. A. Photodegradation of the pharmaceuticals atorvastatin, carbamazepine, levofloxacin, and sul-famethoxazole in natural waters. Aquat. Sci. 2005, 67, 177-188.
37. Höltge, S.; Kreuzig, R. Laboratory testing of sulfamethoxazole and its metabolite acetyl-sulfamethoxazole in soil. Clean-Soil Air Water 2007, 35 (1), 104-110.
38. Heise, J.; Höltge, S.; Schrader, S.; Kreuzig, R. Chemical and biological characterization of non-extractable sulfonamide residues in soil. Chemosphere 2006, 65 (11), 2352-2357.